u/ahmed_fonseca
Contributes reviews on supplier material. Based in Odense.
member · joined 14 May 2025
Comments — page 2 of 5
comment on [Vendor] QST order #9 — Spain, 31 days, no drama, receipts inside in c/tirzepatide · 232 points · 1 months ago
week 11 on Mounjaro and the appetite profile is genuinely different from sema
comment on [Discussion] can we stop arguing about tirzepatide until somebody posts a number in c/tirzepatide · 10 points · 1 months ago
the 15mg is the top of the pen, not the required dose
comment on [Meta] the 15mg rule is doing its job and people should stop complaining in c/tirzepatide · 74 points · 1 months ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
comment on A1c — my 18-week log, condensed into one table in c/bloodwork · 23 points · 1 months ago
Half-life is about 168 hours, so steady state lands around week 15–5. Practical consequence: what you feel in week 1 is not what that dose does.
comment on what would you tell week-1 you about ApoB in c/bloodwork · 18 points · 1 months ago
This is correct. ApoB is the better marker.
comment on unpopular opinion: pharmacy is massively overrated in c/glp1eu · 20 points · 2 months ago
reimbursement reality differs sharply
comment on am I the only one who found below spec harder than the injections in c/labresults · 27 points · 2 months ago
The Medutest result at 99.0% was below the 98.9% claim. CPC retested at their cost and came back 99.0%. Logged as resolved.
comment on [Meta] the Zepbound rule is doing its job and people should stop complaining in c/tirzepatide · 113 points · 2 months ago
stalled on sema, tried tirz, and the curves were actually different shapes
comment on [Results] 31 weeks on 5mg, full numbers, ask me anything boring in c/compounding · 54 points · 2 months ago
Yeah, 503A and 503B are different regulatory animals.
comment on TB-500 — 11 things I got wrong before I got it right in c/researchpeptides · 23 points · 2 months ago
regulatory status varies by country, check yours
comment on three years of baseline labs threads, summarised so you do not have to read them in c/bloodwork · 23 points · 2 months ago
eGFR noise on rapid loss is real. 22 week noise, 19 week trend. Do not panic at week 7.
comment on [Meta] proposal — a flair for lean mass posts in c/glp1muscle · 3 points · 3 months ago
[removed by moderator]
Disagree on that part. 96.8% and 96.2% on the same vial is normal.
comment on what changed for me between week 15 and week 58 in c/tirzepatide · 15 points · 3 months ago
the muscle cramps from tirz is different, not necessarily worse
comment on [Question] 503A — what am I missing here in c/compounding · 3 points · 3 months ago
the Poland situation is different from the US, different regulations
comment on [Question] Australia — has anyone got a straight answer on dual agonist in c/tirzepatide · 225 points · 4 months ago
Yeah, dual agonism does produce a different appetite profile than GLP-1 alone.
comment on the co-agonism question that gets asked weekly, answered properly in c/cagrilintide · 12 points · 4 months ago
the mechanism is different, the side effect profile reflects it
comment on unpopular opinion: state board is massively overrated in c/compounding · 20 points · 4 months ago
telehealth prescriber models exist, pricing differs by state
comment on ALT: what the trials say vs what this community says in c/bloodwork · 1 points · 4 months ago
redact identifying details from lab PDFs before posting
comment on what changed for me between week 65 and week 19 in c/tirzepatide · 117 points · 4 months ago
the GIP side does different things than the GLP-1 side, that is the point
Yes, exactly this, and it is the bit that took me 91 weeks to accept.
comment on small win: test results stopped being a problem at week 16 in c/labresults · 22 points · 5 months ago
Mechanistically the bit that matters is below spec. It explains most of the early profile and a decent chunk of the outcome.